Dianalitics
The Marcus Corporation
MCS · v1 · 2026-08-11
arrow_back
homeHomemonitoringPerformancesearch
hourglass
Loading…
Preparing the latest DD data, styles and content.
65OpportunityDD: Aug 11, 2026Analyst: 68
paidPrice at analysis date
USD 29.9 (11/08/2026)
domainMkt cap
$921M
pie_chartShares
30.83M
candlestick_chart52W
$12.85-$32.42
trending_downShort interest
2.09%
MEDIUMNYSEEntertainment (Theatres + Hotels)2349 employeesFounded 1935
Verdict: Neutral — Momentum priced in

Post-pandemic record Q2 (EBITDA +43%, EPS beat +47%), price up +108% in 12 months, now trading at $29.87 close to 52W-high $32.42. Fundamentals real (both theatres and hotels outperforming their industries), but forward EV/EBITDA of ~12x already prices the film-slate tailwind. Base FV ~$30/sh leaves symmetric R/R: modest upside if H2 slate (Zootopia 2, Avatar 3) delivers, meaningful downside if 2027 film releases disappoint or hotel RevPAR softens.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-08-11
68
The Marcus Corporation (MCS)
Entertainment · NYSE · Milwaukee, WI
"Momentum-led re-rating on real fundamentals — but multiple has largely closed the value gap"
Record post-COVID Q2 Dividend +12.5% Family-controlled (14% insiders) Fwd P/E ~39x Debt/EBITDA 3.1x · Current ratio 0.44
Fin. strength
10
/20 pts
EBITDA/FCF
12
/15 pts
Debt/leverage
8
/15 pts
Stage/business
13
/15 pts
Catalysts
7
/10 pts
Reg. risk
7
/8 pts
Risk/reward
3
/7 pts
Management
4
/5 pts
Sector/macro
2
/3 pts
Compliance
2
/2 pts
💡 Fair Value Estimate — SotP EV/EBITDA (Theatres + Hotels), cross-check EV/Sales
Fair value base case
USD 30.5
Range: USD 27.0-USD 34.0
Price at analysis date: USD 29.9 (11/08/2026)
Base upside/downside: +2%

Primary — SotP EV/EBITDA (theatres 9.5x × $80M FY26E + hotels 11x × $45M FY26E − corporate/leverage). Cross-check — EV/Sales 1.55x × $800M ≈ $29.85/sh (within ±3%). Implied consolidated EV/EBITDA of the base FV = 10.9x, within ±10% of the nominal 10.5x weighted. Multiple sensitivity: ±1x = ±$3.7/sh (12%). The classification as [MOMENTUM] is a selection criterion; this DD independently concludes the stock is fairly valued, with symmetric R/R at current price. ⚠️ Not investment advice.

ComponentAssumptionUSD/share
Theatres EVFY26E EBITDA ~$80M × 9.5x EV/EBITDA (peer CNK 10x, discount −5% for scale)+24.65
Hotels & Resorts EVFY26E EBITDA ~$45M × 11x EV/EBITDA (owned-hotel peer range 10–12x)+16.05
Corporate/overhead−$10M unallocated corporate EBITDA × 9x−2.92
Real estate option25% prob × $90M hidden RE value (own multiple hotel properties, land)+0.73
Net debt($26.4M cash − $320M debt) / 30.83M shs (Jun-30 2026 BS)−8.01
FV base caseSum of components above≈ $30.50
Bull
$38–45
Probability: 25%
H2 2026 blockbuster slate (Zootopia 2, Avatar 3) drives theatre EBITDA to $95M+; hotel RevPAR sustains double-digit gains; multiple re-rates to 12x on sustained momentum. Family monetizes hotel real estate via sale-leaseback.
Base
$27–34
Probability: 50%
FY26E consolidated EBITDA ~$115M with theatres $80M and hotels $45M. Multiple holds at 10–11x. Debt reduction offsets modest share dilution.
Bear
$15–22
Probability: 25%
2027 film pipeline underwhelms (strike overhang), streaming pressure resumes; hotel demand slows on recession; EBITDA reverts to $85M; multiple contracts to 8x. Momentum unwind risk is real (RSI 80).
Methodology: Primary — SotP EV/EBITDA (theatres 9.5x × $80M FY26E + hotels 11x × $45M FY26E − corporate/leverage). Cross-check — EV/Sales 1.55x × $800M ≈ $29.85/sh (within ±3%). Implied consolidated EV/EBITDA of the base FV = 10.9x, within ±10% of the nominal 10.5x weighted. Multiple sensitivity: ±1x = ±$3.7/sh (12%). The classification as [MOMENTUM] is a selection criterion; this DD independently concludes the stock is fairly valued, with symmetric R/R at current price. ⚠️ Not investment advice. Not investment advice.
check_circle
✅ Post-pandemic Q2 record + guidance-consistent operating momentum
Q2 2026 (Jul-30 release): revenue $231.7M (+12.5%), adj EBITDA $46.2M (+43%, post-COVID Q2 record), diluted EPS $0.51 (vs $0.23 PY, beat consensus $0.35 by +47%). Both segments set records: Theatres +14.4% with attendance outperforming industry by >5 pts; Hotels +9% with hotel revenue an all-time Q2 high. Board raised quarterly dividend +12.5% ($0.08→$0.09) on Aug 4. Three of four brokers raised PTs post-print (Wedbush $23→$34, Benchmark $22→$33, Barrington $32→$33); B. Riley downgraded to Neutral on valuation (PT $27→$29).
📊 Capital Structure · Short Interest · Buyback & Dilution
🟢 Short Interest
2.09%
645K shares short on 30.83M outstanding; 2.16 days to cover. Very low SI despite 100%+ 1Y gain — market not fighting the momentum. Squeeze risk immaterial.
🟢 Share dilution (1Y)
−1.81%
From ~31.4M to 30.83M shs outstanding YoY — net reduction via buyback offsets equity comp. Two share classes; insiders (Marcus family) hold 14.4% via Class B.
🟢 Buyback
Active
Buyback yield 1.81% TTM ($17M). Dividend $0.36/yr (raised +12.5% on 2026-08-04 to $0.09/qtr). Shareholder yield ~3.0%. Cash return prioritized over debt paydown.
Short Interest — context
MCS — 2.09%
2.09%

Short interest 2.09% is very low (<5% threshold). Combined with modest float of 21.77M and RSI 80.45, the setup is momentum-friendly but leaves little squeeze potential — the re-rating has been driven by real earnings improvement, not positioning imbalance. No material Form 4 insider selling flagged in the last 12 months per XTX Topco filing (Aug 2025 institutional buy $548K).

$Financial analysis — FY 2026E
Revenue TTM
$747.9M
+1.8% YoY · Q2 26 +12.5%
Adj EBITDA TTM
$102.2M
Margin 12.9% · Q2 26 +43%
Free Cash Flow TTM
$66.7M
FCF yield 7.1% · Capex $60M
Net Debt
$294M
3.13x LTM EBITDA · Coverage 2.9x
ItemFY2023FY2024FY2025LTM Q2-26Guidance 2026E
Revenue ($M)705702735748~780–810
Adj EBITDA ($M)786592102~115–125
Op income ($M)1222536~48–55
Diluted EPS ($)0.16−0.290.470.73~0.95–1.15
Free Cash Flow ($M)45405567~75–90
Note: FY24 was pressured by writers/actors strike aftermath; FY25 recovery accelerating into FY26 on stronger film slate. Guidance ranges are DD estimates from analyst consensus and H1 run-rate (no formal FY guidance from company).
Quarterly dynamics — last 5 quarters
MetricQ2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue ($M)206.0216.0178.5154.4231.7
Adj EBITDA ($M)32.334.521.213.846.2
Op income ($M)13.016.54.2−1.527.1
Diluted EPS ($)0.230.350.05−0.160.51
Net debt EoP ($M)310305300310294
Financial position and sustainability
EBITDA margin (TTM)
12.9% (peer CNK 27%)
FCF conversion (FCF/EBITDA)
65%
Debt / EBITDA
3.13x
Interest coverage (EBIT/Interest)
2.93x
Piotroski F-Score
8 / 9
account_tree

Business model — Diversified entertainment (theatres + hotels)

4th largest US theatre circuit + regional hotel/resort owner-operator
The Marcus Corporation (founded 1935, HQ Milwaukee) operates through two vertically-integrated segments: (1) Marcus Theatres — 4th largest theatre chain in the US with ~85 theatres and ~1,000 screens under the Marcus Theatres, Movie Tavern by Marcus and BistroPlex brands, geographically concentrated in the Midwest with premium format screens (SuperScreen DLX, UltraScreen DLX) and in-theatre dining; (2) Marcus Hotels & Resorts — owner and operator of ~15 full-service hotels and resorts (incl. Pfister Hotel, Grand Geneva Resort, Hilton Milwaukee), plus third-party management services. Founder family (Marcus family) retains ~14.4% ownership and Class B voting control. Key H1 2026 metrics: attendance outperformed industry by 5+ pts (Q2), hotel RevPAR +13.7% Q1, hotel revenue at all-time Q2 high.

Marcus Theatres ~$500–530M FY26E (~65% rev) 🟢 record run 4th-largest US chain, ~85 theatres/1,000 screens, Midwest-concentrated. Segment op income $23.8M H1 26 vs $8.0M PY. Q2 attendance +5pts vs industry. GM heavily correlated to film slate quality — H2 26 catalog (Zootopia 2, Avatar 3, Spider-Man: BND) supports strong run. Structural risk: streaming, secular decline in cinema attendance. Marcus Hotels & Resorts ~$280–300M FY26E (~35% rev) 🟢 RevPAR +13.7% ~15 owned/managed properties incl. flagship Pfister (Milwaukee), Grand Geneva Resort. Hotel revenue at Q2 all-time high, RevPAR outperforming market. Own real estate is hidden-value asset (potential monetization via sale-leaseback). Sensitivity to corporate travel and group bookings. Hospitality mgmt (3rd party) ~$15–20M FY26E (<3% rev) 🟡 sub-scale Third-party hotel management services (check-in, housekeeping, F&B for non-owned properties). Small contribution to total revenue but capital-light, high-margin. Growth optional but not core to thesis.

gavel

Legal, regulatory and risk analysis

Film slate dependency
High
Theatre EBITDA highly correlated to number/quality of studio releases. 2023 strikes still cast shadow on 2027 slate visibility. A single quarter with weak slate can compress EBITDA 30–40%.
Multiple compression risk
High
Stock at $29.87 with fwd P/E ~39x, RSI 80. Any earnings disappointment or macro risk-off could drive multiple back to 8x EBITDA (bear = $15–22).
Leverage & liquidity
Moderate
Net debt $294M, Debt/EBITDA 3.13x, interest coverage 2.93x. Current ratio 0.44 (short-term liab > short-term assets); relies on OCF stability. Not distressed, but not investment-grade.
Streaming secular pressure
Moderate
Long-term theatre attendance below pre-COVID; premium format and F&B partially offset per-cap. Structural, not existential.
Consumer discretionary cyclicality
Moderate
Both hotels (business travel, group bookings) and theatres (out-of-home entertainment) are recession-sensitive. 2027 macro uncertainty is a downside driver.
Governance — dual-class shares
Moderate
Marcus family retains voting control via Class B shares (14.4% ownership). No M&A optionality — takeover unlikely regardless of strategic logic. Aligns long-term but limits activist optionality.
Post-COVID Q2 record baseline
Positive
Q2 2026 EBITDA $46.2M sets new post-pandemic benchmark; combined with H2 slate visibility, sets favorable earnings backdrop for next 2 quarters. Analyst FY26 PT revisions +40–50% (Wedbush, Benchmark).
Hidden real estate value
Positive
Owned hotel properties (Pfister, Grand Geneva) plus fee real estate offer optionality via sale-leaseback or spin. Not currently reflected in equity value; estimated $60–100M incremental value.
article

SWOT analysis

Strengths
  • +Both segments outperforming industry (theatre attendance +5pts, hotel RevPAR +13.7%)
  • +Family-owned since 1935 — long-term operating discipline, aligned incentives
  • +Strong FCF generation ($67M TTM, 7% yield); dividend raised +12.5% Aug 2026
  • +Piotroski F-Score 8/9 — high-quality accruals, improving margins
  • +Low short interest (2.1%) — market not fighting the run
Weaknesses
  • −Consolidated EBITDA margin only 12.9% vs Cinemark 27% (mixed model dilutes)
  • −Leverage 3.13x EBITDA + low current ratio 0.44 = limited financial flexibility
  • −Forward P/E 39x is expensive for cyclical business
  • −Sub-$1B mkt cap + <$3M avg daily volume = limited institutional interest
Opportunities
  • →H2 2026 blockbuster slate: Zootopia 2, Avatar 3, Spider-Man BND (already record)
  • →Hotel real estate monetization (sale-leaseback of Pfister/Grand Geneva)
  • →Group booking recovery — corporate travel still below pre-COVID
  • →Premium format expansion (SuperScreen DLX) — higher per-cap
Threats
  • !2027 film slate visibility low — strike-era production gap risks weak quarter
  • !Streaming windowing shortens theatrical exclusivity long-term
  • !Consumer discretionary recession would hit both divisions simultaneously
  • !Momentum unwind — RSI 80, price 108% up 1Y creates technical vulnerability
article

Summary by assessment area

⚠️ Valuation — Fully Priced
  • Base FV $30.5 vs price $29.87: upside +2%, well below consensus PT $32.25 (+8%)
  • Forward EV/EBITDA 10.8x in-line with theatre peers despite lower margins
  • Bull/base/bear range $15–45 skews symmetric — no clear R/R asymmetry
✅ Operating momentum — Strong
  • Q2 26 post-pandemic EBITDA record; both segments outperformed industry
  • H2 slate visibility strong: Zootopia 2, Avatar 3, Spider-Man BND already booked
  • Dividend +12.5% signals mgmt confidence in cash generation
📊 Balance sheet — Adequate not strong
  • Net debt $294M, 3.1x EBITDA, coverage 2.9x — servicing manageable in base case
  • Current ratio 0.44 — no cushion for a weak quarter or unexpected capex
  • Real estate hidden value optionality partly offsets leverage concern
Sources & Disclaimer

Sources: The Marcus Corporation Q2 2026 press release & earnings call transcript (Jul-30 2026), 10-Q (Jul-30 2026), Business Wire dividend announcement (Aug-04 2026), StockAnalysis.com (Aug-10 2026 close), WallStreetZen (Aug-05 2026), Trefis 52W high list (Aug-10 2026), TheFly analyst notes (Barrington, Wedbush, Benchmark, B. Riley — Jul-31 to Aug-04 2026), Zacks Best Small-Cap Stocks Aug-05 2026. Market data — last verified close 2026-08-10: MCS $29.87 (T-1 vs report date 2026-08-11), market cap ~$921M, 52W: $12.85–$32.42, shares outstanding 30.83M. Short interest: 2.09%. Insider ownership ~14.4% (Marcus family, Class B). ⚠️ This document is for informational purposes only and does not constitute financial or investment advice.